PW Medtech Group (FRA:PWE) Quick Ratio: 10.22 (As of Dec. 2025) — Near Median


FRA:PWE PW Medtech Group Ltd FRA:PWE
83 GF Score
Price €0.11
GF Value €0.13
! 5 Warning Signs
View Full Analysis

What is PW Medtech Group Quick Ratio?

PW Medtech Group FRA:PWE -1.82% 83 Quick Ratio is 10.22 as of Dec. 2025, which is 3% below its 10-year median of 10.54. GuruFocus rates FRA:PWE with a GF Score™ of 83/100 and a GF Value™ of €0.13. The stock has 5 warning signs investors should review. Among 854 Medical Devices & Instruments companies, PW Medtech Group ranks better than 94.96% on this metric.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. PW Medtech Group's quick ratio for the quarter that ended in Dec. 2025 was 10.22.

PW Medtech Group has a quick ratio of 10.22. It generally indicates good short-term financial strength.

The historical rank and industry rank for PW Medtech Group's Quick Ratio or its related term are showing as below:

FRA:PWE' s Quick Ratio Range Over the Past 10 Years
Min: 0.51   Med: 10.54   Max: 29.34
Current: 10.22

During the past 13 years, PW Medtech Group's highest Quick Ratio was 29.34. The lowest was 0.51. And the median was 10.54.

FRA:PWE's Quick Ratio is ranked better than
94.96% of 854 companies
in the Medical Devices & Instruments industry
Industry Median: 1.865 vs FRA:PWE: 10.22

PW Medtech Group  (FRA:PWE) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


PW Medtech Group Quick Ratio Related Terms


PW Medtech Group Quick Ratio Historical Data

* Premium members only.

The historical data trend for PW Medtech Group's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PW Medtech Group Quick Ratio Chart

PW Medtech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.51 10.81 12.70 11.12 10.22

PW Medtech Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.70 9.03 11.12 9.12 10.22

FRA:PWE vs ISRG, BDX, MDLN: Quick Ratio Comparison

For the Medical Instruments & Supplies subindustry, PW Medtech Group's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group Quick Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Quick Ratio distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's Quick Ratio falls into.


FRA:PWE
83GF Score
PW Medtech Group Ltd FRA:PWE
Quick Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PW Medtech Group Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

PW Medtech Group's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Quick Ratio (A: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(286.298-17.606)/26.287
=10.22

PW Medtech Group's Quick Ratio for the quarter that ended in Dec. 2025 is calculated as

Quick Ratio (Q: Dec. 2025 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(286.298-17.606)/26.287
=10.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 10.22 mean?
PW Medtech Group (FRA:PWE) has a Quick Ratio of 10.22 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PW Medtech Group and its competitors. This is near median its historical median of 10.54. Over the past decade, PW Medtech Group's Quick Ratio has ranged from 0.51 to 29.34. According to the industry distribution chart, PW Medtech Group ranks #43 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 5%.
Is PW Medtech Group's Quick Ratio too high?
PW Medtech Group's current Quick Ratio of 10.22 is near median its 10-year median of 10.54. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 29.34. The Medical Devices & Instruments industry median Quick Ratio is 1.87. PW Medtech Group's value of 10.22 is 448% above this industry median. Based on the distribution chart, PW Medtech Group ranks #43 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, PW Medtech Group has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does PW Medtech Group's Quick Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PW Medtech Group ranks #43 out of 854 companies for Quick Ratio. This places PW Medtech Group in the top 5% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.87. PW Medtech Group's value of 10.22 is 448% above this benchmark. Historically, PW Medtech Group's own Quick Ratio has ranged from 0.51 to 29.34 over the past decade. While the company's 10-year median is 10.54 vs. the industry median of 1.87, PW Medtech Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PW Medtech Group's current Quick Ratio of 10.22 is 448% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PW Medtech Group and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PW Medtech Group's current Quick Ratio is 10.22, which is near median its own 10-year median of 10.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PW Medtech Group stock overvalued right now?
PW Medtech Group (FRA:PWE) has a current Quick Ratio of 10.22. The stock's GF Value™ is €0.13, compared to a current price of €0.11 — trading 16.9% below its estimated fair value. The current Quick Ratio is 10.22, which is near median its 10-year median of 10.54 and 448% above the Medical Devices & Instruments industry median of 1.87. PW Medtech Group's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For PW Medtech Group (FRA:PWE), the current Quick Ratio is 10.22 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PW Medtech Group (FRA:PWE) Overvalued in 2026?

Based on GuruFocus' analysis, PW Medtech Group stock appears to be undervalued. The current stock price of €0.11 is trading 16.9% below its estimated GF Value™ of €0.13.

Key valuation signals for FRA:PWE:

  • Quick Ratio: 10.22 (near median its 10-year median of 10.54)
  • GF Value™: €0.13 vs. price of €0.11 (16.9% below fair value)
  • GF Score™: 83/100 with 5 warning signs
  • Industry Position: 448% above the Medical Devices & Instruments median (#43 of 854)

No single metric tells the full story. See the FRA:PWE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PW Medtech Group Business Description

Other Exchanges 01358:Hong Kong
Address No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company focused on China's medical device industry. The Group operates in infusion sets, blood purification products, and regenerative medical biomaterials. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, insulin needles and pens, high flux and low flux hemodialyzers, hemodiafilters, hemoperfutors, and dialysis machines. Its segments are Infusion Set Business, Blood Purification Business, which represents the R&D, manufacturing, and sales of hemodialysis and blood purification medical devices, and Regenerative Medical Biomaterials Business, which generates maximum revenue. Geographically, it operates in China, North America, India and Others.
83GF Score

Get the complete analysis for FRA:PWE

Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.11
Price
€0.13
GF Value